Therapeutics and COVID-19-A living WHO guideline : Endorsement by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine

Almenn færsla
dc.contributor.authorMøller, Morten H
dc.contributor.authorChew, Michelle S
dc.contributor.authorOlkkola, Klaus T
dc.contributor.authorRehn, Marius
dc.contributor.authorYli-Hankala, Arvi
dc.contributor.authorSigurðsson, Martin Ingi
dc.contributor.departmentFaculty of Medicine
dc.date.accessioned2025-11-20T08:43:57Z
dc.date.available2025-11-20T08:43:57Z
dc.date.issued2022-02-28
dc.descriptionFunding Information: Funding was provided from the Scandinavian Society of Anaesthesiology and Intensive Care Medicine and institutional and/or departmental sources. Publisher Copyright: © 2022 The Authors. Acta Anaesthesiologica Scandinavica published by John Wiley & Sons Ltd on behalf of Acta Anaesthesiologica Scandinavica Foundation.en
dc.description.abstractThe Clinical Practice Committee of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine endorses the Living WHO guideline on therapeutics and COVID-19. This trustworthy continuously updated guideline serves as a highly useful decision aid for Nordic anaesthesiologists caring for patients with COVID-19.en
dc.description.versionPeer revieweden
dc.format.extent2
dc.format.extent366299
dc.format.extent636-637
dc.identifier.citationMøller, M H, Chew, M S, Olkkola, K T, Rehn, M, Yli-Hankala, A & Sigurðsson, M I 2022, 'Therapeutics and COVID-19-A living WHO guideline : Endorsement by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine', Acta Anaesthesiologica Scandinavica, vol. 66, no. 5, pp. 636-637. https://doi.org/10.1111/aas.14046en
dc.identifier.doi10.1111/aas.14046
dc.identifier.issn0001-5172
dc.identifier.other48356120
dc.identifier.other38a07989-6a8a-4243-acd9-1d96757a7d13
dc.identifier.other35170027
dc.identifier.otherunpaywall: 10.1111/aas.14046
dc.identifier.other85125900433
dc.identifier.urihttps://hdl.handle.net/20.500.11815/6683
dc.language.isoen
dc.relation.ispartofseriesActa Anaesthesiologica Scandinavica; 66(5)en
dc.relation.urlhttps://www.scopus.com/pages/publications/85125900433en
dc.rightsinfo:eu-repo/semantics/openAccessen
dc.subjectAnesthesiologyen
dc.subjectCOVID-19en
dc.subjectCritical Careen
dc.subjectHumansen
dc.subjectSocieties, Medicalen
dc.subjectWorld Health Organizationen
dc.subjecttherapeuticsen
dc.subjectAGREE IIen
dc.subjectclinical practice guidelineen
dc.subjectWHOen
dc.subjectAnesthesiology and Pain Medicineen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.titleTherapeutics and COVID-19-A living WHO guideline : Endorsement by the Scandinavian Society of Anaesthesiology and Intensive Care Medicineen
dc.type/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/articleen

Skrár

Original bundle

Niðurstöður 1 - 1 af 1
Nafn:
Therapeutics_....pdf
Stærð:
357.71 KB
Snið:
Adobe Portable Document Format
Hlaða niður

Undirflokkur

Háskóli Íslands

Öll gögn í Opnum vísindum eru vernduð af ákvæðum höfundalaga og með öllum réttindum áskildum, nema annað sé tekið fram.